If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Magdalena Plebanksi is an internationally-recognised and award-winning researcher.

Her focus is on developing practical and affordable vaccines and treatments for complex diseases like malaria and cancer. She has also pioneered the use of synthetic size-defined non-inflammatory nanoparticles in vaccines. 

Magdalena has forged a stellar career in medical and health research. She came to Australia from Oxford University in the UK, where she showed new ways in which malaria parasites can trick the human immune system.  More recently, her insights have been used to help understand cancer progression across multiple human clinical trials, particularly leukemia and ovarian cancer.

Her nanoparticle studies also opened the door to new nanotechnology applications to prevent allergic airways disease. She has more than 50 patents in 10 patent families, which have supported the formation of biotechnology companies.

Magdalena has published more than 150 peer-reviewed full-length papers, including in leading journals such as LancetNatureScienceImmunityNature BiotechnologyNature Medicine and Nature Communications among others, and has secured funding from national and international grant bodies, as well as charitable and commercial funding.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Malaria
  • Cancer
  • Nanoparticles
  • Immunology
  • Allergic airways disease

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or